Myriad Genetics Inc (MYGN) — Capital Reinvestment Ratio

Latest as of December 2025: 0.57x

Myriad Genetics Inc (MYGN) has a Capital Reinvestment Ratio of 0.57x as of December 2025, meaning it reinvests 1% of its operating cash flow ($10.60 Million) in capital expenditures ($6.00 Million). See MYGN cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.57x
Capex / Operating Cash Flow

Operating Cash Flow

$10.60 Million
USD

Capital Expenditures

$6.00 Million
USD

Data as of

Dec 2025
Most recent filing

Myriad Genetics Inc Capital Reinvestment Ratio (1995–2025)

This chart tracks Myriad Genetics Inc's Capital Reinvestment Ratio across 17 annual periods.

Annual Capital Reinvestment Ratio for Myriad Genetics Inc (1995–2025)

Year-by-year Capital Reinvestment Ratio for Myriad Genetics Inc from 1995 to 2025. For live market cap and broader valuation context, see how much is Myriad Genetics Inc worth.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 15.22x $1.80 Million $27.40 Million ▲ +1473.0%
2021 0.97x $18.60 Million $18.00 Million ▲ +841.9%
2020 0.10x $83.70 Million $8.60 Million ▲ +0.0%
2019 0.10x $83.70 Million $8.60 Million ▲ +41.8%
2018 0.07x $115.90 Million $8.40 Million ▲ +26.2%
2017 0.06x $106.20 Million $6.10 Million ▲ +91.0%
2016 0.03x $166.30 Million $5.00 Million ▼ -82.3%
2015 0.17x $140.50 Million $23.90 Million ▲ +126.3%
2014 0.08x $190.20 Million $14.30 Million ▲ +14.7%
2013 0.07x $173.90 Million $11.40 Million ▼ -8.5%
2012 0.07x $141.80 Million $10.16 Million ▲ +61.8%
2011 0.04x $130.83 Million $5.79 Million ▼ -13.0%
2010 0.05x $155.09 Million $7.89 Million ▼ -43.1%
2009 0.09x $84.04 Million $7.53 Million ▼ -32.1%
2008 0.13x $103.74 Million $13.68 Million ▼ -51.0%
2000 0.27x $17.16 Million $4.62 Million ▼ -94.1%
1995 4.57x $1.40 Million $6.40 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow